Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
Watchlist
Compare
1.790
+0.020 (1.13%)
Aug 14, 2025, 1:48 PM - Market open
Overview
Financials
Forecast
Statistics
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Full Width
Fiscal Year
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Period Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
T Cell Receptor-engineered T Cell
2.82M
Log In
Log In
Log In
Log In
T Cell Receptor-engineered T Cell Growth
-86.62%
Log In
Log In
Log In
Log In
Revenue by Geography
Fiscal year is January - December.
Download
Full Width
Fiscal Year
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Period Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
United States
2.82M
Log In
Log In
Log In
Log In
United States Growth
-86.62%
Log In
Log In
Log In
Log In
